Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells
Giant cell tumors of bone (GCTB) are semi-malignant tumors associated with extensive osteolytic defects and massive bone destructions. They display a locally aggressive behavior and a very high recurrence rate. Recently, a single mutation has been identified in GCTB affecting the H3F3A gene coding f...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
8 February 2019
|
| In: |
Cancer letters
Year: 2019, Volume: 448, Pages: 61-69 |
| ISSN: | 1872-7980 |
| DOI: | 10.1016/j.canlet.2019.02.001 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1016/j.canlet.2019.02.001 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0304383519300631 |
| Author Notes: | J. Fellenberg, H. Sähr, D. Mancarella, C. Plass, A.M. Lindroth, F. Westhauser, B. Lehner, V. Ewerbeck |
| Summary: | Giant cell tumors of bone (GCTB) are semi-malignant tumors associated with extensive osteolytic defects and massive bone destructions. They display a locally aggressive behavior and a very high recurrence rate. Recently, a single mutation has been identified in GCTB affecting the H3F3A gene coding for the histone variant H3.3 (H3.3-G34W). The aim of this study was to investigate whether H3.3-G34W is sufficient to drive tumorigenesis in GCTB. Initially, we confirmed the high frequency of this mutation in 94% of 84 analyzed tissue samples. Using a siRNA based approach we could selectively knockdown H3.3-G34W in primary neoplastic stromal cells isolated from tumor tissue (GCTSC). H3.3-G34W knockdown caused a significant inhibition of cell proliferation, migration and colony formation capacity in vitro. Xenotransplantation of GCTSCs onto the chorioallantoic membrane of fertilized chicken eggs further demonstrated a significant impact of H3.3-G34W knockdown on tumor engraftment and growth in vivo. Our data indicate that H3.3-G34W is sufficient to drive tumorigenesis in GCTB. Apart from the application of H3.3-G34W screening as diagnostic tool, our data suggest that H3.3-G4W represents a promising target for the development of new GCTB therapies. |
|---|---|
| Item Description: | Gesehen am 09.07.2019 |
| Physical Description: | Online Resource |
| ISSN: | 1872-7980 |
| DOI: | 10.1016/j.canlet.2019.02.001 |